Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2007

01.11.2007 | Epidemiology

Predictive factors for late normal tissue complications following radiotherapy for breast cancer

verfasst von: Carmen Lilla, Christine B. Ambrosone, Silke Kropp, Irmgard Helmbold, Peter Schmezer, Dietrich von Fournier, Wulf Haase, Marie-Luise Sautter-Bihl, Frederik Wenz, Jenny Chang-Claude

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Abstract

Background and purpose

Radiotherapy after breast-conserving surgery is commonly applied to reduce recurrence of breast cancer but may cause acute and late side effects. To identify prognostic factors for the development of late toxicity after radiotherapy, we conducted a prospective study of breast cancer patients.

Patients and methods

We assessed late complications of radiotherapy and collected information on epidemiologic factors in a cohort of breast cancer patients who had received radiotherapy after breast-conserving surgery. Among 416 patients with complete follow-up data, the association between possible risk factors and development of late complications was evaluated using multivariate logistic regression analysis.

Results

After a median follow-up time of 51 months, 131 (31.4%) patients presented with telangiectasia and 28 (6.7%) patients with fibrosis. We observed a strong association between development of telangiectasia and fibrosis (p < 0.01). Increasing age of the patient was a risk factor for both telangiectasia and fibrosis (p-value for trend <0.01 and 0.03, respectively). Patients with acute skin toxicity (odds ratio (OR) 1.8, 95% confidence interval (CI) 1.0–3.1) were at higher risk to develop telangiectasia. Long-term smoking was associated with a significant increase in risk of telangiectasia compared to non-smokers (OR 2.3, 95% CI 1.2–4.6).

Conclusions

Our study revealed several factors other than radiation dose that may predispose to late complications following radiotherapy. Further understanding of differences in response to irradiation may advance individualized treatment and improve cosmetic outcome.
Literatur
1.
Zurück zum Zitat Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233–1241PubMedCrossRef Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233–1241PubMedCrossRef
2.
Zurück zum Zitat Fehlauer F, Tribius S, Alberti W, Rades D (2005) Late effects and cosmetic results of conventional versus hypofractionated irradiation in breast-conserving therapy. Strahlenther Onkol 181:625–631PubMedCrossRef Fehlauer F, Tribius S, Alberti W, Rades D (2005) Late effects and cosmetic results of conventional versus hypofractionated irradiation in breast-conserving therapy. Strahlenther Onkol 181:625–631PubMedCrossRef
3.
Zurück zum Zitat Johansson S, Svensson H, Denekamp J (2002) Dose response and latency for radiation-induced fibrosis, edema, and neuropathy in breast cancer patients. Int J Radiat Oncol Biol Phys 52:1207–1219PubMedCrossRef Johansson S, Svensson H, Denekamp J (2002) Dose response and latency for radiation-induced fibrosis, edema, and neuropathy in breast cancer patients. Int J Radiat Oncol Biol Phys 52:1207–1219PubMedCrossRef
4.
Zurück zum Zitat Borger JH, Kemperman H, Smitt HS, Hart A, van Dongen J, Lebesque J, Bartelink H (1994) Dose and volume effects on fibrosis after breast conservation therapy. Int J Radiat Oncol Biol Phys 30:1073–1081PubMed Borger JH, Kemperman H, Smitt HS, Hart A, van Dongen J, Lebesque J, Bartelink H (1994) Dose and volume effects on fibrosis after breast conservation therapy. Int J Radiat Oncol Biol Phys 30:1073–1081PubMed
5.
Zurück zum Zitat Bowden SJ, Fernando IN, Burton A (2006) Delaying radiotherapy for the delivery of adjuvant chemotherapy in the combined modality treatment of early breast cancer: is it disadvantageous and could combined treatment be the answer? Clin Oncol (R Coll Radiol) 18:247–256 Bowden SJ, Fernando IN, Burton A (2006) Delaying radiotherapy for the delivery of adjuvant chemotherapy in the combined modality treatment of early breast cancer: is it disadvantageous and could combined treatment be the answer? Clin Oncol (R Coll Radiol) 18:247–256
6.
Zurück zum Zitat Dikomey E, Borgmann K, Peacock J, Jung H (2003) Why recent studies relating normal tissue response to individual radiosensitivity might have failed and how new studies should be performed. Int J Radiat Oncol Biol Phys 56:1194–1200PubMedCrossRef Dikomey E, Borgmann K, Peacock J, Jung H (2003) Why recent studies relating normal tissue response to individual radiosensitivity might have failed and how new studies should be performed. Int J Radiat Oncol Biol Phys 56:1194–1200PubMedCrossRef
7.
Zurück zum Zitat Twardella D, Chang-Claude J (2002) Studies on radiosensitivity from an epidemiological point of view—overview of methods and results. Radiother Oncol 62:249–260PubMedCrossRef Twardella D, Chang-Claude J (2002) Studies on radiosensitivity from an epidemiological point of view—overview of methods and results. Radiother Oncol 62:249–260PubMedCrossRef
8.
Zurück zum Zitat Bentzen SM, Overgaard J (1994) Patient-to-Patient Variability in the Expression of Radiation-Induced Normal Tissue Injury. Semin Radiat Oncol 4:68–80PubMedCrossRef Bentzen SM, Overgaard J (1994) Patient-to-Patient Variability in the Expression of Radiation-Induced Normal Tissue Injury. Semin Radiat Oncol 4:68–80PubMedCrossRef
9.
Zurück zum Zitat Twardella D, Popanda O, Helmbold I, Ebbeler R, Benner A, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Schmezer P, Chang-Claude J (2003) Personal characteristics, therapy modalities and individual DNA repair capacity as predictive factors of acute skin toxicity in an unselected cohort of breast cancer patients receiving radiotherapy. Radiother Oncol 69:145–153PubMedCrossRef Twardella D, Popanda O, Helmbold I, Ebbeler R, Benner A, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Schmezer P, Chang-Claude J (2003) Personal characteristics, therapy modalities and individual DNA repair capacity as predictive factors of acute skin toxicity in an unselected cohort of breast cancer patients receiving radiotherapy. Radiother Oncol 69:145–153PubMedCrossRef
10.
Zurück zum Zitat Cancer Therapy Evaluation Program (1998) Common Toxicity Criteria. Available at http://ctep.cancer.gov/reporting/ctc.html. National Institutes of Health Cancer Therapy Evaluation Program (1998) Common Toxicity Criteria. Available at http://​ctep.​cancer.​gov/​reporting/​ctc.​html.​ National Institutes of Health
11.
Zurück zum Zitat Seegenschmiedt MH (1998) Interdisciplinary documentation of treatment side effects in oncology. Present status and perspectives. Strahlenther Onkol 174(Suppl 3):25–29PubMed Seegenschmiedt MH (1998) Interdisciplinary documentation of treatment side effects in oncology. Present status and perspectives. Strahlenther Onkol 174(Suppl 3):25–29PubMed
12.
Zurück zum Zitat Turesson I, Nyman J, Holmberg E, Oden A (1996) Prognostic factors for acute and late skin reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys 36:1065–1075PubMedCrossRef Turesson I, Nyman J, Holmberg E, Oden A (1996) Prognostic factors for acute and late skin reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys 36:1065–1075PubMedCrossRef
13.
Zurück zum Zitat Vrieling C, Collette L, Fourquet A, Hoogenraad WJ, Horiot JC, Jager JJ, Pierart M, Poortmans PM, Struikmans H, Van der HM, Van der SE, Bartelink H (1999) The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC “boost versus no boost” trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer. Int J Radiat Oncol Biol Phys 45:677–685 Vrieling C, Collette L, Fourquet A, Hoogenraad WJ, Horiot JC, Jager JJ, Pierart M, Poortmans PM, Struikmans H, Van der HM, Van der SE, Bartelink H (1999) The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC “boost versus no boost” trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer. Int J Radiat Oncol Biol Phys 45:677–685
14.
Zurück zum Zitat Moody AM, Mayles WP, Bliss JM, A’Hern RP, Owen JR, Regan J, Broad B, Yarnold JR (1994) The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity. Radiother Oncol 33:106–112 Moody AM, Mayles WP, Bliss JM, A’Hern RP, Owen JR, Regan J, Broad B, Yarnold JR (1994) The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity. Radiother Oncol 33:106–112
15.
Zurück zum Zitat Bentzen SM, Overgaard M (1993) Early and late normal tissue injury after postmastectomy radiotherapy. Recent Results Cancer Res 130:59–78PubMed Bentzen SM, Overgaard M (1993) Early and late normal tissue injury after postmastectomy radiotherapy. Recent Results Cancer Res 130:59–78PubMed
16.
Zurück zum Zitat Bentzen SM, Overgaard M, Thames HD (1989) Fractionation sensitivity of a functional endpoint: impaired shoulder movement after post-mastectomy radiotherapy. Int J Radiat Oncol Biol Phys 17:531–537PubMed Bentzen SM, Overgaard M, Thames HD (1989) Fractionation sensitivity of a functional endpoint: impaired shoulder movement after post-mastectomy radiotherapy. Int J Radiat Oncol Biol Phys 17:531–537PubMed
17.
Zurück zum Zitat Vrieling C, Collette L, Fourquet A, Hoogenraad WJ, Horiot JH, Jager JJ, Pierart M, Poortmans PM, Struikmans H, Maat B, Van Limbergen E, Bartelink H (2000) The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC ‘boost vs. no boost’ trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. Radiother Oncol 55:219–232PubMedCrossRef Vrieling C, Collette L, Fourquet A, Hoogenraad WJ, Horiot JH, Jager JJ, Pierart M, Poortmans PM, Struikmans H, Maat B, Van Limbergen E, Bartelink H (2000) The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC ‘boost vs. no boost’ trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. Radiother Oncol 55:219–232PubMedCrossRef
18.
Zurück zum Zitat Taylor ME, Perez CA, Halverson KJ, Kuske RR, Philpott GW, Garcia DM, Mortimer JE, Myerson RJ, Radford D, Rush C (1995) Factors influencing cosmetic results after conservation therapy for breast cancer. Int J Radiat Oncol Biol Phys 31:753–764PubMedCrossRef Taylor ME, Perez CA, Halverson KJ, Kuske RR, Philpott GW, Garcia DM, Mortimer JE, Myerson RJ, Radford D, Rush C (1995) Factors influencing cosmetic results after conservation therapy for breast cancer. Int J Radiat Oncol Biol Phys 31:753–764PubMedCrossRef
19.
Zurück zum Zitat Hazane F, Sauvaigo S, Douki T, Favier A, Beani JC (2006) Age-dependent DNA repair and cell cycle distribution of human skin fibroblasts in response to UVA irradiation. J Photochem Photobiol B 82:214–223PubMedCrossRef Hazane F, Sauvaigo S, Douki T, Favier A, Beani JC (2006) Age-dependent DNA repair and cell cycle distribution of human skin fibroblasts in response to UVA irradiation. J Photochem Photobiol B 82:214–223PubMedCrossRef
20.
Zurück zum Zitat Gorbunova V, Seluanov A (2005) Making ends meet in old age: DSB repair and aging. Mech Ageing Dev 126:621–628PubMedCrossRef Gorbunova V, Seluanov A (2005) Making ends meet in old age: DSB repair and aging. Mech Ageing Dev 126:621–628PubMedCrossRef
21.
Zurück zum Zitat Lombard DB, Chua KF, Mostoslavsky R, Franco S, Gostissa M, Alt FW (2005) DNA repair, genome stability, and aging. Cell 120:497–512PubMedCrossRef Lombard DB, Chua KF, Mostoslavsky R, Franco S, Gostissa M, Alt FW (2005) DNA repair, genome stability, and aging. Cell 120:497–512PubMedCrossRef
22.
23.
Zurück zum Zitat Rogers PB, Plowman PN, Harris SJ, Arlett CF (2000) Four radiation hypersensitivity cases and their implications for clinical radiotherapy. Radiother Oncol 57:143–154PubMedCrossRef Rogers PB, Plowman PN, Harris SJ, Arlett CF (2000) Four radiation hypersensitivity cases and their implications for clinical radiotherapy. Radiother Oncol 57:143–154PubMedCrossRef
24.
Zurück zum Zitat Tutt A, Yarnold J (2006) Radiobiology of breast cancer. Clin Oncol (R Coll Radiol) 18:166–178 Tutt A, Yarnold J (2006) Radiobiology of breast cancer. Clin Oncol (R Coll Radiol) 18:166–178
25.
Zurück zum Zitat Moullan N, Cox DG, Angele S, Romestaing P, Gerard JP, Hall J (2003) Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. Cancer Epidemiol Biomarkers Prev 12:1168–1174PubMed Moullan N, Cox DG, Angele S, Romestaing P, Gerard JP, Hall J (2003) Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. Cancer Epidemiol Biomarkers Prev 12:1168–1174PubMed
26.
Zurück zum Zitat De Ruyck K, Wilding CS, Van Eijkeren M, Morthier R, Tawn EJ, Thierens H (2005) Microsatellite polymorphisms in DNA repair genes XRCC1, XRCC3 and XRCC5 in patients with gynecological tumors: association with late clinical radiosensitivity and cancer incidence. Radiat Res 164:237–244PubMedCrossRef De Ruyck K, Wilding CS, Van Eijkeren M, Morthier R, Tawn EJ, Thierens H (2005) Microsatellite polymorphisms in DNA repair genes XRCC1, XRCC3 and XRCC5 in patients with gynecological tumors: association with late clinical radiosensitivity and cancer incidence. Radiat Res 164:237–244PubMedCrossRef
27.
Zurück zum Zitat Angele S, Romestaing P, Moullan N, Vuillaume M, Chapot B, Friesen M, Jongmans W, Cox DG, Pisani P, Gerard JP, Hall J (2003) ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity. Cancer Res 63:8717–8725PubMed Angele S, Romestaing P, Moullan N, Vuillaume M, Chapot B, Friesen M, Jongmans W, Cox DG, Pisani P, Gerard JP, Hall J (2003) ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity. Cancer Res 63:8717–8725PubMed
28.
Zurück zum Zitat Chang-Claude J, Popanda O, Tan XL, Kropp S, Helmbold I, von FD, Haase W, Sautter-Bihl ML, Wenz F, Schmezer P, Ambrosone CB (2005) Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clin Cancer Res 11:4802–4809 Chang-Claude J, Popanda O, Tan XL, Kropp S, Helmbold I, von FD, Haase W, Sautter-Bihl ML, Wenz F, Schmezer P, Ambrosone CB (2005) Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clin Cancer Res 11:4802–4809
29.
Zurück zum Zitat Tan XL, Popanda O, Ambrosone CB, Kropp S, Helmbold I, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Schmezer P, Chang-Claude J (2005) Association between TP53 and p21 genetic polymorphisms and acute side effects of radiotherapy in breast cancer patients. Breast Cancer Res Treat 1–8 Tan XL, Popanda O, Ambrosone CB, Kropp S, Helmbold I, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Schmezer P, Chang-Claude J (2005) Association between TP53 and p21 genetic polymorphisms and acute side effects of radiotherapy in breast cancer patients. Breast Cancer Res Treat 1–8
30.
Zurück zum Zitat Hoeller U, Borgmann K, Bonacker M, Kuhlmey A, Bajrovic A, Jung H, Alberti W, Dikomey E (2003) Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancer. Radiother Oncol 69:137–144PubMedCrossRef Hoeller U, Borgmann K, Bonacker M, Kuhlmey A, Bajrovic A, Jung H, Alberti W, Dikomey E (2003) Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancer. Radiother Oncol 69:137–144PubMedCrossRef
31.
Zurück zum Zitat Barber JB, Burrill W, Spreadborough AR, Levine E, Warren C, Kiltie AE, Roberts SA, Scott D (2000) Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer. Radiother Oncol 55:179–186PubMedCrossRef Barber JB, Burrill W, Spreadborough AR, Levine E, Warren C, Kiltie AE, Roberts SA, Scott D (2000) Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer. Radiother Oncol 55:179–186PubMedCrossRef
32.
Zurück zum Zitat Bentzen SM, Overgaard M (1991) Relationship between early and late normal-tissue injury after postmastectomy radiotherapy. Radiother Oncol 20:159–165PubMedCrossRef Bentzen SM, Overgaard M (1991) Relationship between early and late normal-tissue injury after postmastectomy radiotherapy. Radiother Oncol 20:159–165PubMedCrossRef
33.
Zurück zum Zitat Gehrig J, Hacki WH, Schulthess HK, Reinisch E, Kunz J, Stamm B (1987) [Radiation proctocolitis following gynecologic radiotherapy: an endoscopic study]. Schweiz Med Wochenschr 117:1326–1332PubMed Gehrig J, Hacki WH, Schulthess HK, Reinisch E, Kunz J, Stamm B (1987) [Radiation proctocolitis following gynecologic radiotherapy: an endoscopic study]. Schweiz Med Wochenschr 117:1326–1332PubMed
34.
Zurück zum Zitat Bohler FK, Rhomberg W, Doringer W (1992) [Hypertension as risk factor for increased rate of side effects in the framework of breast carcinoma irradiation]. Strahlenther Onkol 168:344–349PubMed Bohler FK, Rhomberg W, Doringer W (1992) [Hypertension as risk factor for increased rate of side effects in the framework of breast carcinoma irradiation]. Strahlenther Onkol 168:344–349PubMed
35.
Zurück zum Zitat Moore DE (2002) Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management. Drug Saf 25:345–372PubMedCrossRef Moore DE (2002) Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management. Drug Saf 25:345–372PubMedCrossRef
36.
Zurück zum Zitat Ferreira MA (2003) Cytokine expression in allergic inflammation: systematic review of in vivo challenge studies. Mediators Inflamm 12:259–267PubMedCrossRef Ferreira MA (2003) Cytokine expression in allergic inflammation: systematic review of in vivo challenge studies. Mediators Inflamm 12:259–267PubMedCrossRef
37.
Zurück zum Zitat Rubin P, Johnston CJ, Williams JP, McDonald S, Finkelstein JN (1995) A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys 33:99–109PubMedCrossRef Rubin P, Johnston CJ, Williams JP, McDonald S, Finkelstein JN (1995) A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys 33:99–109PubMedCrossRef
38.
Zurück zum Zitat Vujaskovic Z, Anscher MS, Feng QF, Rabbani ZN, Amin K, Samulski TS, Dewhirst MW, Haroon ZA (2001) Radiation-induced hypoxia may perpetuate late normal tissue injury. Int J Radiat Oncol Biol Phys 50:851–855PubMedCrossRef Vujaskovic Z, Anscher MS, Feng QF, Rabbani ZN, Amin K, Samulski TS, Dewhirst MW, Haroon ZA (2001) Radiation-induced hypoxia may perpetuate late normal tissue injury. Int J Radiat Oncol Biol Phys 50:851–855PubMedCrossRef
39.
Zurück zum Zitat Gorlewska-Roberts K, Green B, Fares M, Ambrosone CB, Kadlubar FF (2002) Carcinogen-DNA adducts in human breast epithelial cells. Environ Mol Mutagen 39:184–192PubMedCrossRef Gorlewska-Roberts K, Green B, Fares M, Ambrosone CB, Kadlubar FF (2002) Carcinogen-DNA adducts in human breast epithelial cells. Environ Mol Mutagen 39:184–192PubMedCrossRef
40.
Zurück zum Zitat Perera FP, Estabrook A, Hewer A, Channing K, Rundle A, Mooney LA, Whyatt R, Phillips DH (1995) Carcinogen-DNA adducts in human breast tissue. Cancer Epidemiol Biomarkers Prev 4:233–238PubMed Perera FP, Estabrook A, Hewer A, Channing K, Rundle A, Mooney LA, Whyatt R, Phillips DH (1995) Carcinogen-DNA adducts in human breast tissue. Cancer Epidemiol Biomarkers Prev 4:233–238PubMed
41.
Zurück zum Zitat Hecht SS (2003) Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer 3:733–744PubMedCrossRef Hecht SS (2003) Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer 3:733–744PubMedCrossRef
42.
Zurück zum Zitat Terhaard CH, Snippe K, Ravasz LA, van dT I, Hordijk GJ (1991) Radiotherapy in T1 laryngeal cancer: prognostic factors for locoregional control and survival, uni- and multivariate analysis. Int J Radiat Oncol Biol Phys 21:1179–1186PubMed Terhaard CH, Snippe K, Ravasz LA, van dT I, Hordijk GJ (1991) Radiotherapy in T1 laryngeal cancer: prognostic factors for locoregional control and survival, uni- and multivariate analysis. Int J Radiat Oncol Biol Phys 21:1179–1186PubMed
43.
Zurück zum Zitat Rugg T, Saunders MI, Dische S (1990) Smoking and mucosal reactions to radiotherapy. Br J Radiol 63:554–556PubMedCrossRef Rugg T, Saunders MI, Dische S (1990) Smoking and mucosal reactions to radiotherapy. Br J Radiol 63:554–556PubMedCrossRef
44.
Zurück zum Zitat Johansson S, Svensson H, Denekamp J (2000) Timescale of evolution of late radiation injury after postoperative radiotherapy of breast cancer patients. Int J Radiat Oncol Biol Phys 48:745–750PubMedCrossRef Johansson S, Svensson H, Denekamp J (2000) Timescale of evolution of late radiation injury after postoperative radiotherapy of breast cancer patients. Int J Radiat Oncol Biol Phys 48:745–750PubMedCrossRef
Metadaten
Titel
Predictive factors for late normal tissue complications following radiotherapy for breast cancer
verfasst von
Carmen Lilla
Christine B. Ambrosone
Silke Kropp
Irmgard Helmbold
Peter Schmezer
Dietrich von Fournier
Wulf Haase
Marie-Luise Sautter-Bihl
Frederik Wenz
Jenny Chang-Claude
Publikationsdatum
01.11.2007
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2007
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-006-9480-9

Weitere Artikel der Ausgabe 1/2007

Breast Cancer Research and Treatment 1/2007 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.